Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction
- PMID: 215096
- DOI: 10.1001/archpsyc.1978.01770280111012
Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction
Abstract
Buprenorphine was evaluated for its abuse potential and utility in treating narcotic addiction. The drug was morphine-like but was 25 to 50 times more potent than morphine and was longer-acting. Little if any physical dependence of clinical significance was produced by buprenorphine. The effects of morphine to 120-mg doses were blocked by buprenorphine, a blockade that persisted for 29 1/2 hours. In man, buprenorphine has less intrinsic activity than morphine, and as such, as a low abuse potential. Moreover, the drug has potential for treating narcotic addiction since it is acceptable to addicts, is long-acting, produces a low level of physical dependence such that patients may be easily detoxified, is less toxic than drugs used for maintenance therapy, and blocks the effects of narcotics.
Similar articles
-
Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts.Drug Alcohol Depend. 1998 Mar 1;50(1):1-8. doi: 10.1016/s0376-8716(98)00008-8. Drug Alcohol Depend. 1998. PMID: 9589267 Clinical Trial.
-
Nalbuphine.Drug Alcohol Depend. 1985 Feb;14(3-4):339-62. doi: 10.1016/0376-8716(85)90066-3. Drug Alcohol Depend. 1985. PMID: 2986929 Review.
-
Buprenorphine and naloxone interactions in methadone maintenance patients.Biol Psychiatry. 1997 Jun 1;41(11):1095-101. doi: 10.1016/S0006-3223(96)00266-1. Biol Psychiatry. 1997. PMID: 9146820 Clinical Trial.
-
Buprenorphine.Drug Alcohol Depend. 1985 Feb;14(3-4):363-72. doi: 10.1016/0376-8716(85)90067-5. Drug Alcohol Depend. 1985. PMID: 2986930 Review.
-
Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.Pharmacopsychiatry. 2002 Sep;35(5):159-64. doi: 10.1055/s-2002-34115. Pharmacopsychiatry. 2002. PMID: 12237786 Clinical Trial.
Cited by
-
Effect of plasma proteins on buprenorphine transfer across dually perfused placental lobule.J Matern Fetal Neonatal Med. 2009 Aug;22(8):646-53. doi: 10.1080/14767050802610328. J Matern Fetal Neonatal Med. 2009. PMID: 19544152 Free PMC article.
-
Buprenorphine Treatment for Opioid Use Disorder: An Overview.CNS Drugs. 2019 Jun;33(6):567-580. doi: 10.1007/s40263-019-00637-z. CNS Drugs. 2019. PMID: 31062259 Free PMC article. Review.
-
Buprenorphine-naloxone therapy in pain management.Anesthesiology. 2014 May;120(5):1262-74. doi: 10.1097/ALN.0000000000000170. Anesthesiology. 2014. PMID: 24509068 Free PMC article. Review.
-
Why aren't physicians prescribing more buprenorphine?J Subst Abuse Treat. 2017 Jul;78:1-7. doi: 10.1016/j.jsat.2017.04.005. Epub 2017 Apr 12. J Subst Abuse Treat. 2017. PMID: 28554597 Free PMC article.
-
Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol.Biol Psychol. 2006 Jul;73(1):90-9. doi: 10.1016/j.biopsycho.2006.01.010. Epub 2006 Feb 23. Biol Psychol. 2006. PMID: 16497429 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical